Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF JULY 02, 2025 SAM #8619
SPECIAL NOTICE

A -- Development and Implementation of COVID-19 Immune Assay(s) Development and Implementation

Notice Date

6/30/2025 11:50:49 AM
 

Notice Type

Justification
 

NAICS

541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
 

Contracting Office

ASPR BARDA DIV CONTRACTS MGMT & ACQ Washington DC 20515 USA
 

ZIP Code

20515
 

Solicitation Number

BARDA-IEIDD-063025
 

Archive Date

07/30/2025
 

Point of Contact

Jill Johnson, Contracting Officer, Phone: 202-816-11484
 

E-Mail Address

jill.johnson@hhs.gov
(jill.johnson@hhs.gov)
 

Award Number

75A50123C00045
 

Award Date

09/29/2023
 

Description

This procurement is aimed at providing a central laboratory capacity site for analysis of mucosal and serum samples collected from subjects enrolled in multiple USG-sponsored COVID-19 vaccine trials. This action covers efforts to utilize the validated virus neutralization (VN) and binding assays to support these studies. The program goals are: 1. Establish validated VN and binding assays for SARS-CoV-2 emerging variant(s). 2. Test serum samples from human subjects enrolled in clinical trials of COVID-19 vaccine candidates in variant VN and binding antibody assays in compliance with GCLP guidelines.
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/f4eb98d18fa441c0b1883cda9980e36f/view)
 

Place of Performance

Address: NC 28401, USA

Zip Code: 28401

Country: USA
 

Record

SN07493155-F 20250702/250630230041 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |